[The clinicoimmunological evaluation of the use of timogeksin in different forms of measles].
Materials are submitted concerning the use of thymohexine in the treatment of measles. Efficacy of thymohexine in 133 children with grave and complicated forms of measles was assessed. Thymohexine was found out to reduce the duration of the infectious toxicosis and local inflammatory events. Under the influence of the above drug the total counts of T- and B-lymphocytes (CD11, CD8, CD4, CD22) returned to normal as did the immunoregulatory index (D4/CD8), levels of circulating immune complexes, their molecular composition.
Ershova
I B
IB
D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000917:Antibody Formation / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007113:Immunity, Innate / Q000187:drug effects; D007223:Infant; D008457:Measles / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D009842:Oligopeptides / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D009842:Oligopeptides; C080035:thymohexin
Kliniko-immunologicheskaia otsenka primeneniia timogeksina pri razlichnykh formakh kori.